2011
DOI: 10.1038/469139a
|View full text |Cite|
|
Sign up to set email alerts
|

Cancer trial errors revealed

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
8
0

Year Published

2012
2012
2017
2017

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 24 publications
(8 citation statements)
references
References 5 publications
0
8
0
Order By: Relevance
“…Again, however, the lack of a universally recognized tagging system linking investigators to their deposited data has hindered authors from receiving due credit [9]. Recent scandals relating to falsified data that went long undetected in medicine [10] and psychology [11] also highlight the need to make data easily accessible for purposes of validation and to maintain public trust in science. One notable attempt to address the issues of gaining complete access to data is the Dryad repository, which serves as a storehouse for smaller datasets directly affiliated with publications in the biosciences [12].…”
Section: Discussionmentioning
confidence: 99%
“…Again, however, the lack of a universally recognized tagging system linking investigators to their deposited data has hindered authors from receiving due credit [9]. Recent scandals relating to falsified data that went long undetected in medicine [10] and psychology [11] also highlight the need to make data easily accessible for purposes of validation and to maintain public trust in science. One notable attempt to address the issues of gaining complete access to data is the Dryad repository, which serves as a storehouse for smaller datasets directly affiliated with publications in the biosciences [12].…”
Section: Discussionmentioning
confidence: 99%
“…Second, diagnostic and prognostic gene signatures contain a large number of genes and the prediction algorithms are complex and not easy to use routinely in clinics (16). Third, the development of complex molecular tests based on DNA, RNA, proteins or metabolite profiles carries a series of problems inherent to all high-throughput techniques where large datasets are analyzed (17). Selecting the statistically significant results from a large dataset containing also nonsignificant data is challenging, because when multiple significance tests are calculated the probability that at least one reaches by chance significance increases with the number of tests performed (18).…”
Section: Transcriptomics and Proteomicsmentioning
confidence: 99%
“…It is therefore critical to control this multiplicity problem as well as to use one or more model validation technique for assessing how the results of a statistical analysis will generalize to an independent dataset (18). However, in the race to apply genomics technology, genomics works are too frequently published in which massive quantities of data containing avoidable errors are handled (17). Yet, when used correctly microarray technologies may be translated into score systems that can reproducibly predict clinical outcomes.…”
Section: Transcriptomics and Proteomicsmentioning
confidence: 99%
“…The original paper was published in 2006 14 , and received high acknowledgement by other scientists as having significant contribution to the research field of cancer treatment. However, the research was shown in 2009 by two bioinformatic statisticians, Baggerly and Coombes, to contain incorrect data 15 17 . In this case, patient health may not have been compromised, because the treatment program at Duke was terminated as soon as it was discovered that there is suspicion of data manipulation.…”
mentioning
confidence: 94%